Medicines for the People Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 6
- Latest action
- Mar 5, 2026
What it does
The Medicines for the People Act would establish a National Institute for Biomedical Research and Development within the Public Health Service Act to conduct full-cycle development of drugs, devices, and biological products, with a focus on ensuring equitable and accessible pricing for the public. The Institute would manage research, acquire inventions from NIH-supported work, own resulting patents and trade secrets, and license them under public interest terms—including free licensing to public and nonprofit entities and cost-plus pricing for for-profit entities—while requiring transparency in data sharing and prioritizing projects based on public health impact and unmet needs. It would…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.